Expression of GNAZ, encoding the Gαz protein, predicts survival in mantle cell lymphoma

Br J Haematol. 2019 May;185(4):708-712. doi: 10.1111/bjh.15810. Epub 2019 Feb 20.

Abstract

Mantle cell lymphoma (MCL), a malignancy of B-lymphocytes, has a poor prognosis. It is thus necessary to improve the understanding of the pathobiology of MCL and identify factors contributing to its aggressiveness. Our studies, based on Affymetrix data from 17 MCL biopsies, real-time quantitative polymerase chain reaction data from 18 sorted primary MCL cells and 108 MCL biopsies compared to non-malignant tissue, reveals that GNAZ expression predicts poor clinical outcome of MCL patients (Cox regression, P = 0·014) and lymphocytosis (Mann-Whitney, P = 0·011). We show that GNAZ translates to Gαz protein - a signalling molecule within the G-protein coupled receptor network. Our findings suggest that GNAZ/Gαz contribute to the MCL pathobiology.

Keywords: G-protein coupled receptors; G-proteins; lymphocytosis; mantle cell lymphoma; prognosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Down-Regulation / physiology
  • GTP-Binding Protein alpha Subunits / genetics
  • GTP-Binding Protein alpha Subunits / metabolism*
  • Humans
  • Kaplan-Meier Estimate
  • Lymphoma, Mantle-Cell / genetics
  • Lymphoma, Mantle-Cell / metabolism
  • Lymphoma, Mantle-Cell / mortality*
  • RNA / metabolism
  • RNA Interference / physiology
  • Real-Time Polymerase Chain Reaction

Substances

  • GNAZ protein, human
  • GTP-Binding Protein alpha Subunits
  • RNA